Adaptimmune Therapeutics PLC (ADAP)
1.01
+0.03
(+3.41%)
USD |
NASDAQ |
Apr 22, 16:00
1.03
+0.02
(+1.98%)
After-Hours: 20:00
Adaptimmune Therapeutics Price to Book Value: 6.309 for April 22, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 22, 2024 | 6.309 |
| April 19, 2024 | 6.101 |
| April 18, 2024 | 5.612 |
| April 17, 2024 | 6.166 |
| April 16, 2024 | 6.434 |
| April 15, 2024 | 6.559 |
| April 12, 2024 | 7.246 |
| April 11, 2024 | 8.058 |
| April 10, 2024 | 7.933 |
| April 09, 2024 | 8.558 |
| April 08, 2024 | 8.496 |
| April 05, 2024 | 8.558 |
| April 04, 2024 | 8.433 |
| April 03, 2024 | 8.620 |
| April 02, 2024 | 8.745 |
| April 01, 2024 | 9.183 |
| March 28, 2024 | 9.870 |
| March 27, 2024 | 9.870 |
| March 26, 2024 | 9.495 |
| March 25, 2024 | 8.995 |
| March 22, 2024 | 8.995 |
| March 21, 2024 | 8.371 |
| March 20, 2024 | 8.308 |
| March 19, 2024 | 8.808 |
| March 18, 2024 | 9.183 |
| Date | Value |
|---|---|
| March 15, 2024 | 9.245 |
| March 14, 2024 | 9.120 |
| March 13, 2024 | 9.932 |
| March 12, 2024 | 9.308 |
| March 11, 2024 | 9.620 |
| March 08, 2024 | 10.93 |
| March 07, 2024 | 10.87 |
| March 06, 2024 | 10.68 |
| March 05, 2024 | 9.120 |
| March 04, 2024 | 9.245 |
| March 01, 2024 | 9.141 |
| February 29, 2024 | 9.026 |
| February 28, 2024 | 9.256 |
| February 27, 2024 | 9.831 |
| February 26, 2024 | 9.429 |
| February 23, 2024 | 8.509 |
| February 22, 2024 | 7.934 |
| February 21, 2024 | 8.624 |
| February 20, 2024 | 7.244 |
| February 16, 2024 | 6.899 |
| February 15, 2024 | 7.186 |
| February 14, 2024 | 7.359 |
| February 13, 2024 | 6.870 |
| February 12, 2024 | 6.956 |
| February 09, 2024 | 7.186 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.5163
Minimum
Nov 15 2019
10.93
Maximum
Mar 08 2024
2.667
Average
2.305
Median
Mar 24 2021
Price to Book Value Benchmarks
| Biodexa Pharmaceuticals Plc | 0.5629 |
| NuCana PLC | 0.4449 |
| Autolus Therapeutics PLC | 10.90 |
| Mereo BioPharma Group PLC | 7.743 |
| TC BioPharm (Holdings) PLC | 1.476 |
Price to Book Value Related Metrics
| PS Ratio | 3.372 |
| Price | 1.01 |
| Earnings Yield | -46.91% |
| Market Cap | 249.29M |